Minerva Biotechnologies Corporation is categorized under Financial Consultants in Sandpoint, ID and active since 2007.
Minerva Biotechnologies Corporation was established in 2007, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Financial Consultants business, which does work in the B2B market, and is classified as a Financial Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact James Czirr at the company’s single location by writing to 425 Janish Drive, Sandpoint, Idaho ID 83864 or by phoning (208) 263-6695. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Minerva Biotechnologies Corporation |
| Contact Person: | James Czirr |
| Address: | 425 Janish Drive, Sandpoint, Idaho 83864 |
| Phone Number: | (208) 263-6695 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Financial Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Minerva Biotechnologies Corporation was started in 2007 to provide professional Financial Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact James Czirr for inquiries that concern Minerva Biotechnologies Corporation by calling the company number (208) 263-6695, as your correspondence is most welcome. Additionally, the physical location of the single location of Minerva Biotechnologies Corporation can be found at the coordinates 48.294145,-116.631557 as well as the street address 425 Janish Drive in Sandpoint, Idaho 83864.
For its online presence, you may visit Minerva Biotechnologies Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.